Article

Easing the Economic and Clinical Burden of Psoriasis and Psoriatic Arthritis: The Role of Managed Care

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Steven Daveluy, MD, dermatologist, Wayne State University
April Armstrong, MD, MPH, chief of dermatology, UCLA
April Armstrong, MD, MPH, chief of dermatology, UCLA
Related Content
traffic-related air pollution | Sergiy Serdyuk - stock.adobe.com
August 19th 2025

Air Pollution, Genes Together Raise Psoriasis Risk, Study Finds

Pearl Steinzor
Psoriasis as an Inflammatory Disease, and What’s Changed Over Time
August 19th 2025

Psoriasis as an Inflammatory Disease, and What’s Changed Over Time

Biosimilars. | Image Credit: Shutter2U - stock.adobe.com
August 19th 2025

Switching Biologics in Psoriasis Boosts Effectiveness but Raises Infection Risk

Pearl Steinzor
Family planning/consult | Image credit: Satori Studio - stock.adobe.com
August 19th 2025

Patients With Psoriasis Seek Better Family Planning Guidance

Pearl Steinzor
Apremilast | luchschenF - stock.adobe.com
August 19th 2025

Apremilast Maintains Efficacy at 2 Years in Pediatric Psoriasis

Pearl Steinzor
Cardiovascular heart arteries AI - hirakun - AdobeStock_1191397495 (1).jpeg
August 19th 2025

Diabetes Increases Cardiovascular Risk in Patients With Psoriasis, Coronary Artery Disease

Pearl Steinzor

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo